✦ LIBER ✦

Treatment of advanced colorectal cancer

✍ Scribed by Richard L. Nelson

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 227 KB
Volume: 12
Category: Article
ISSN: 8756-0437
DOI: 10.1002/(sici)1098-2388(199607/08)12:4<217::aid-ssu2>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Alfred M. Cohen 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

5-fluorouracil and isoprinosine in the t

5-fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation

✍ Mariantonietta Colozza; Maurizio Tonato; Virginio Belsanti; Anna Maria Mosconi; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

A phase III trial of 5-fluorouracil and

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study

✍ Michael J. O'Connell 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

Operative treatment of colorectal cancer

✍ Herand Abcarian 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Radiation therapy for advanced colorecta

Radiation therapy for advanced colorectal cancer

✍ Colin A. Poulter 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Treatment of advanced male breast cancer

✍ William G. Kraybill; Richard Kaufman; David Kinne 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 1 views

The modalities used to treat 27 male patients with metastatic breast cancer at Memorial Hospital from 1957-1979 are reviewed. The overall objective orchiectomy response rate was 48% (11123). The median response was 11 months (6-96 months). The median survival in responders was 58 months, whereas the